HSV-1716
N/A
Report date: 2024/01/02 20:03:52
Base Information
Drug NameHSV-1716
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVirttu Biologics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteVirttu Biologics Ltd
Active IndicationsN/A
Inactive Indications +[6]
Other Information
ATC CodeN/A
Related LinksN/A